• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GH Research PLC - Ordinary Shares (NQ:GHRS)

13.15 -0.94 (-6.67%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about GH Research PLC - Ordinary Shares

< Previous 1 2 Next >
News headline image
GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD
March 25, 2026
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports Full Year 2025 Financial Results and Provides Business Update
March 05, 2026
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026
January 05, 2026
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research to Announce IND Status for GH001
January 02, 2026
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 06, 2025
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress
October 09, 2025
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 07, 2025
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Announces Global Pivotal Program Plans and Further Development Updates
July 23, 2025
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule
June 20, 2025
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual Meeting
May 15, 2025
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates
May 08, 2025
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports Full Year 2024 Financial Results and Provides Business Updates
February 27, 2025
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Announces Pricing of $150 Million Public Offering
February 04, 2025
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Announces Proposed Public Offering
February 03, 2025
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Announces Primary Endpoint Met in Phase 2b Trial with GH001 in TRD Demonstrating -15.5 Point Placebo-adjusted MADRS Reduction
February 03, 2025
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research to Provide Update on Phase 2b Trial with GH001 in TRD
January 31, 2025
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents
January 10, 2025
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 14, 2024
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates
September 03, 2024
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer
September 03, 2024
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
May 03, 2024
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
February 29, 2024
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression
January 18, 2024
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports Third Quarter Financial Results and Provides Business Updates
November 09, 2023
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression
September 29, 2023
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 23, 2023
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights
May 11, 2023
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports Full Year 2022 Financial Results and Provides Business Updates
March 02, 2023
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Provides Business Updates and Highlights Key Upcoming Milestones
January 09, 2023
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports Third Quarter 2022 Financial Results and Provides Business Updates
November 10, 2022
From GH Research PLC
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap